Cigar News: Cigar Industry Files for Summary Judgment on FDA's Final Deeming Rule

Cigar News: Cigar Industry Files for Summary Judgment on FDA’s Final Deeming Rule

Cigar News: Cigar Industry Files for Summary Judgment on FDA's Final Deeming RuleCigar Industry Lawsuit Against FDA’s Deeming Rule Moves Forward

FOR IMMEDIATE RELEASE- -February 14, 2017

WASHINGTON, D.C. – Yesterday, in the U.S. District Court for the District of Columbia, the Cigar Association of America, the International Premium Cigar & Pipe Retailers Association and Cigar Rights of America filed a Motion for Summary Judgment and opening brief in the cigar industry’s litigation challenging the FDA’s Final Deeming Rule.

This filing serves as the next phase in the premium cigar industry’s joint litigation challenging FDA’s Final Deeming Rule, which began earlier this year in July with the Cigar Association of America, et al. v. Food and Drug Administration, et al. lawsuit in the same court.

In filing the summary motion, the three industry associations are petitioning the court to vacate and set aside the Deeming rule because it is unlawful and in violation of the Administrative Procedures Act as well as the First and Fifth Amendments to the Constitution.

Among the arguments made in the filing are the following:

  • FDA’s Final Rule improperly subjected cigars and pipe tobacco to all aspects of the regulations;
  • FDA arbitrarily imposed premarket review provisions without clarifying the substantial equivalence pathway for cigars and pipe tobacco;
  • FDA impermissibly denied to cigars and pipe tobacco of the same stay of enforcement pending review of premarket applications as was provided to cigarettes;
  • FDA rejected “Option 2” exempting premium cigars from regulation without any basis;
  • FDA’s decision to impose user fees on some, but not all, of the newly deemed products is contrary to law and exceeds statutory authority;
  • FDA’s Final Rule is based on a flawed cost-benefit analysis and imposes an unreasonable burden on small businesses;
  • FDA’s Final Rule warning label requirements violate the First Amendment; and
  • FDA unreasonably imposed the new warning label requirements without making statutorily mandated findings.

Speaking about the filing, Glynn Loope, Executive Director of Cigar Rights of America said, “The premium cigar industry continues its adamant objection to the Deeming Rule and its defective implementation. This process has resulted in premium hand-made cigars being subjected to requirements that will cause irreparable economic harm to this artisan industry, and the Main Street America small businesses that rely upon it. We trust that the merits of our argument will demonstrate to the court that the Deeming Rule is fundamentally flawed and legally deficient.”

The hearing on the joint industry lawsuit is schedule to be held on July 28, 2017. Cigar Rights of America will continue to provide updates as we move through the next phases of the litigation.